Opioids

After careful consideration, the FDA has requested that a particular opioid analgesic be removed from the market.

The FDA approved Vantrela ER tablets for the management of severe pain requiring daily opioid treatment which alternative treatment options have proven inadequate.

The FDA has approved a long-acting opioid painkiller designed to be difficult to crush, manipulate, and abuse.

The FDA has approved a new opioid that features specific properties designed to deter, but not prevent, abuse.